Literature DB >> 24934285

Elevated serum uric acid is associated with angiotensinogen in obese patients with untreated hypertension.

Junxia Zhang1, Yuping Zhang, Wuquan Deng, Bing Chen.   

Abstract

This study investigated the correlation between elevated serum uric acid (SUA) and angiotensinogen in obesity patients with hypertension. A total of 162 obese and 162 nonobese men with hypertension were recruited in this study. Plasma angiotensinogen levels were measured by enzyme-linked immunosorbent assay. Fasting insulin (FINS) was evaluated by radioimmunoassay. Compared with nonobese patients, obese patients exhibited higher levels of angiotensinogen, FINS, and homeostasis model assessment index-insulin resistance (HOMA-IR) (P<.001 for all). Moreover, these indexes significantly increased in obese patients in the highest tertile of SUA when compared with those in the lowest tertile of SUA (P<.001, P=.002, P=.007, respectively). In the obese group, SUA levels were significantly related to angiotensinogen, FINS, and HOMA-IR, respectively. Furthermore, it was demonstrated that obesity × uric acid was an independent contributor to angiotensinogen (β=0.257, P<.001). In conclusion, elevated SUA is strongly related to angiotensinogen in an obesity-dependent manner in hypertension.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24934285      PMCID: PMC8031571          DOI: 10.1111/jch.12353

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  35 in total

1.  Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice.

Authors:  Frederique Yiannikouris; Michael Karounos; Richard Charnigo; Victoria L English; Debra L Rateri; Alan Daugherty; Lisa A Cassis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-09       Impact factor: 3.619

2.  Resurrection of uric acid as a causal risk factor in essential hypertension.

Authors:  Richard J Johnson; Dan I Feig; Jaime Herrera-Acosta; Duk-Hee Kang
Journal:  Hypertension       Date:  2004-11-22       Impact factor: 10.190

3.  Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome.

Authors:  Tae Woo Yoo; Ki Chul Sung; Hun Sub Shin; Byung Jin Kim; Bum Soo Kim; Jin Ho Kang; Man Ho Lee; Jung Ro Park; Hyang Kim; Eun Jung Rhee; Won Young Lee; Sun Woo Kim; Seung Ho Ryu; Dong Geuk Keum
Journal:  Circ J       Date:  2005-08       Impact factor: 2.993

Review 4.  Diagnosis and management of hypertension in obesity.

Authors:  K Narkiewicz
Journal:  Obes Rev       Date:  2006-05       Impact factor: 9.213

5.  Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation.

Authors:  F Massiéra; M Bloch-Faure; D Ceiler; K Murakami; A Fukamizu; J M Gasc; A Quignard-Boulange; R Negrel; G Ailhaud; J Seydoux; P Meneton; M Teboul
Journal:  FASEB J       Date:  2001-10-15       Impact factor: 5.191

6.  Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.

Authors:  Hiroaki Masuzaki; Hiroshi Yamamoto; Christopher J Kenyon; Joel K Elmquist; Nicholas M Morton; Janice M Paterson; Hiroshi Shinyama; Matthew G F Sharp; Stewart Fleming; John J Mullins; Jonathan R Seckl; Jeffrey S Flier
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  Incidence and precursors of hypertension in young adults: the Framingham Offspring Study.

Authors:  R J Garrison; W B Kannel; J Stokes; W P Castelli
Journal:  Prev Med       Date:  1987-03       Impact factor: 4.018

8.  Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue.

Authors:  Laurent Yvan-Charvet; Florence Massiéra; Noël Lamandé; Gérard Ailhaud; Michèle Teboul; Naima Moustaid-Moussa; Jean-Marie Gasc; Annie Quignard-Boulangé
Journal:  Endocrinology       Date:  2008-10-23       Impact factor: 4.736

9.  Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II.

Authors:  C Karlsson; K Lindell; M Ottosson; L Sjöström; B Carlsson; L M Carlsson
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

10.  Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country.

Authors:  D Conen; V Wietlisbach; P Bovet; C Shamlaye; W Riesen; F Paccaud; M Burnier
Journal:  BMC Public Health       Date:  2004-03-25       Impact factor: 3.295

View more
  8 in total

1.  Effect of Febuxostat, a Xanthine Oxidase Inhibitor, on Cardiovascular Risk in Hyperuricemic Patients with Hypertension: A Prospective, Open-label, Pilot Study.

Authors:  Shigemasa Tani; Ken Nagao; Atsushi Hirayama
Journal:  Clin Drug Investig       Date:  2015-12       Impact factor: 2.859

2.  Preterm Birth Is Associated with Higher Uric Acid Levels in Adolescents.

Authors:  Lisa K Washburn; Patricia A Nixon; Gregory B Russell; Beverly M Snively; T Michael O'Shea
Journal:  J Pediatr       Date:  2015-04-11       Impact factor: 4.406

3.  Hypertension and obesity: correlates with renin-angiotensin-aldosterone system and uric acid.

Authors:  Gema Ruiz-Hurtado; Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-06-23       Impact factor: 3.738

4.  Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study.

Authors:  Jon V Norvik; Hilde M Storhaug; Kirsti Ytrehus; Trond G Jenssen; Svetlana N Zykova; Bjørn O Eriksen; Marit D Solbu
Journal:  BMC Cardiovasc Disord       Date:  2016-05-10       Impact factor: 2.298

5.  What is the most important determinant of cardiometabolic risk in 60-65-year-old subjects: physical activity-related behaviours, overall energy expenditure or occupational status? A cross-sectional study in three populations with different employment status in Poland.

Authors:  Bartłomiej Konrad Sołtysik; Joanna Kostka; Kamil Karolczak; Cezary Watała; Tomasz Kostka
Journal:  BMJ Open       Date:  2019-07-30       Impact factor: 2.692

6.  Relation of serum uric acid to an exaggerated systolic blood pressure response to exercise testing in men with normotension.

Authors:  Sae Young Jae; Kanokwan Bunsawat; Yoon-Ho Choi; Yeon Soo Kim; Rhian M Touyz; Jeong Bae Park; Barry A Franklin
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-19       Impact factor: 3.738

7.  Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: A study on Bangladeshi adults.

Authors:  Nurshad Ali; Rasheda Perveen; Shahnaz Rahman; Shakil Mahmood; Sadaqur Rahman; Shiful Islam; Tangigul Haque; Abu Hasan Sumon; Rahanuma Raihanu Kathak; Noyan Hossain Molla; Farjana Islam; Nayan Chandra Mohanto; Shaikh Mirja Nurunnabi; Shamim Ahmed; Mustafizur Rahman
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

8.  Severe Hypouricemia Impairs Endothelium-Dependent Vasodilatation and Reduces Blood Pressure in Healthy Young Men: A Randomized, Placebo-Controlled, and Crossover Study.

Authors:  Benjamin De Becker; Catherine Coremans; Martin Chaumont; Cédric Delporte; Pierre Van Antwerpen; Thierry Franck; Alexandre Rousseau; Karim Zouaoui Boudjeltia; Pierre Cullus; Philippe van de Borne
Journal:  J Am Heart Assoc       Date:  2019-11-22       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.